Spurdle AB - Search Results

1

Breastfeeding and Endometrial Cancer Risk: An Analysis From the Epidemiology of Endometrial Cancer Consortium.

Jordan SJ, Na R, Johnatty SE, Wise LA, Adami HO, Brinton LA, Chen C, Cook LS, Dal Maso L, De Vivo I, Freudenheim JL, Friedenreich CM, La Vecchia C, McCann SE, Moysich KB, Lu L, Olson SH, Palmer JR, Petruzella S, Pike MC, Rebbeck TR, Ricceri F, Risch HA, Sacerdote C, Setiawan VW, Sponholtz TR, Shu XO, Spurdle AB, Weiderpass E, Wentzensen N, Yang HP, Yu H, Webb PM. Jordan SJ, et al. Among authors: spurdle ab. Obstet Gynecol. 2017 Jun;129(6):1059-1067. doi: 10.1097/AOG.0000000000002057. Obstet Gynecol. 2017. PMID: 28486362 Free PMC article.

2

CYP17 promotor polymorphism and ovarian cancer risk.

Spurdle AB, Chen X, Abbazadegan M, Martin N, Khoo SK, Hurst T, Ward B, Webb PM, Chenevix-Trench G. Spurdle AB, et al. Int J Cancer. 2000 May 1;86(3):436-9. doi: 10.1002/(sici)1097-0215(20000501)86:3<436::aid-ijc21>3.0.co;2-a. Int J Cancer. 2000. PMID: 10760835 Free article.

3

Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer.

Spurdle AB, Webb PM, Chen X, Martin NG, Giles GG, Hopper JL, Chenevix-Trench G. Spurdle AB, et al. Int J Cancer. 2000 Sep 1;87(5):637-43. Int J Cancer. 2000. PMID: 10925355 Free article.

4

Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype.

Spurdle AB, Webb PM, Purdie DM, Chen X, Green A, Chenevix-Trench G. Spurdle AB, et al. Carcinogenesis. 2001 Jan;22(1):67-72. doi: 10.1093/carcin/22.1.67. Carcinogenesis. 2001. PMID: 11159743

5

The microsomal epoxide hydrolase Tyr113His polymorphism: association with risk of ovarian cancer.

Spurdle AB, Purdie DM, Webb PM, Chen X, Green A, Chenevix-Trench G. Spurdle AB, et al. Mol Carcinog. 2001 Jan;30(1):71-8. doi: 10.1002/1098-2744(200101)30:1<71::aid-mc1015>3.0.co;2-9. Mol Carcinog. 2001. PMID: 11255266

6

No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer.

Spurdle AB, Webb PM, Purdie DM, Chen X, Green A, Chenevix-Trench G. Spurdle AB, et al. Carcinogenesis. 2001 May;22(5):717-21. doi: 10.1093/carcin/22.5.717. Carcinogenesis. 2001. PMID: 11323389

7

Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer.

Webb PM, Hopper JL, Newman B, Chen X, Kelemen L, Giles GG, Southey MC, Chenevix-Trench G, Spurdle AB. Webb PM, et al. Among authors: spurdle ab. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):319-23. doi: 10.1158/1055-9965.EPI-04-0335. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15734952

8

The role of glutathione-S-transferase polymorphisms in ovarian cancer survival.

Nagle CM, Chenevix-Trench G, Spurdle AB, Webb PM. Nagle CM, et al. Among authors: spurdle ab. Eur J Cancer. 2007 Jan;43(2):283-90. doi: 10.1016/j.ejca.2006.09.011. Epub 2006 Nov 3. Eur J Cancer. 2007. PMID: 17084623

9

Ovarian cancer survival and polymorphisms in hormone and DNA repair pathway genes.

Nagle CM, Chenevix-Trench G, Webb PM, Spurdle AB. Nagle CM, et al. Among authors: spurdle ab. Cancer Lett. 2007 Jun 18;251(1):96-104. doi: 10.1016/j.canlet.2006.11.011. Epub 2006 Dec 19. Cancer Lett. 2007. PMID: 17182175

10

Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.

Johnatty SE, Spurdle AB, Beesley J, Chen X, Hopper JL, Duffy DL, Chenevix-Trench G; Kathleen Cuningham Consortium for Research in Familial Breast Cancer. Johnatty SE, et al. Among authors: spurdle ab. Breast Cancer Res Treat. 2008 May;109(1):91-9. doi: 10.1007/s10549-007-9627-3. Epub 2007 Jun 26. Breast Cancer Res Treat. 2008. PMID: 17592773

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

463 results

Search Page